Back to search

Article

Evaluation of Gremlin-1 as a therapeutic target in metabolic dysfunction-associated steatohepatitis

2024-01-05

Abstract excerpt

Gremlin-1 has been implicated in liver fibrosis in metabolic dysfunction-associated steatohepatitis (MASH) via inhibition of bone-morphogenetic protein (BMP) signalling and has thereby been identified as a potential therapeutic target. Using rat in vivo and human in vitro and ex vivo model systems of MASH fibrosis, we show that neutralisation of Gremlin-1 activity with monoclonal therapeutic antibodies does not...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
95d7bb96-78c1-5c4c-b41f-cb969a7d308f
DOI
10.1101/2024.01.03.574043
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Evaluation of Gremlin-1 as a therapeutic target in metabolic dysfunction-associated steatohepatitisDOI 10.1101/2024.01.03.574043
Select a neighboring publication to make it the new centre.